Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA And Beijing-based RDPAC Call For Innovative Medicines To Support China’s Healthcare Reform

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - The Pharmaceutical Research and Manufacturers of America and the Beijing-based R&D Pharmaceutical Association Committee that represents Big Pharma in China, recently submitted a paper to the Chinese government to help the government better understand the role of innovative medicines in the ongoing healthcare reform in China
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC071655

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel